Displaying items by tag: adults
If you are interested in seeing if you may qualify for an ongoing clinical study, please contact Christina Ndolo at cmndolo@uabmc.edu.
- Between the ages of 11 and 19?
- Feeling sad, down, or hopeless?
- Feeling guilty, tense, or irritable?
If so, you may be eligible to participate in a non-treatment research study.
Compensation provided for both parent and child, if applicable.
For more information, please contact the UAB Office of Psychiatric Clinical Research at (205) 934-2484.
-----------------------------------------------------------------------
We Need Healthy Adolescent Controls!
- Are you in good physical health?
- Are you between the ages of 11 and 19?
- Do you have NO history of Depression?
If so, you may be eligible to participate in a non-treatment research study.
Compensation provided for both parent and child, if applicable.
For more information, please contact the UAB Office of Psychiatric Clinical Research at (205) 934-2484.
Do you have NO history of Depression?
Are you eager to participate in research?
If so, you maybe be eligible to participate in a non-treatment study. Compensation provided.
For more information, please call the UAB Office of Psychiatric Research at (205) 934-2484.
- 18-60 years old?
- Feeling sad, down, hopeless?
- Experiencing increase or decrease in appetite?
- Experiencing loss of interest in activities?
- Having difficulty concentrating?
- Sleeping too little or too much?
- Wishing you were dead?
If so, you may be eligible to participate in a non-treatment research study. Compensation provided.
For more information, please call the UAB Office of Psychiatric Research at (205) 934-2484.
https://redcap.musc.edu/surveys/?s=8JWFT9XFY3FYR7Y3
About the Clinical Trial:
The purpose of this NIH funded trial is to examine the effects of three different diabetes treatments to determine if they improve night-time blood sugars.
This Trial Involves:
- A screening visit that includes a blood draw, urine test and physical exam
- Treatment with Metformin, Insulin Glargine (long-acting insulin) or the experimental drug Dorzagliatin which is FDA-approved for research, for up to 8 weeks
- 2-4 inpatient visits/ including two overnight stays at the Clinical Research Unit at 15th floor of Jefferson Tower.
All visits to be completed within a three-month period. Study-related tests and procedures are provided free of charge. Participants will be compensated up to $2,500 for study completion. All Participants must be Diagnosed with type 2 DM and Not on any type of insulin therapy.
Please contact Kathryn Hollifield-Laumer at khollifield@uabmc.edu or co-investigators Chanel Mason at 205-934-1921 or cnmason@uabmc.edu, or Alaaeldin Hodhod at ahodhod@uabmc.edu.
This is a great opportunity for all to gain experience participating in a clinical research study. All participation would not only contribute to advancing our understanding of perceptual learning and how the brain processes vision, but also holds the potential to improve outcomes for those with central vision loss.
If you or someone you know may be interested, please consider participating.
For more information or to express interest, please email mcmaxwell@uabmc.edu or text or call 205-410-4041, or visit go.uab.edu/brainstudy to sign up!
Thank you for your time and consideration!
Participants between the ages of 35 and 65 are needed for this study. The purpose of the study is to fill in what we don’t know about how schizophrenia affects people as they get older. We want to find out what we can do to help older individuals with schizophrenia live better lives. The study includes 4 visits over the course of two weeks. The screening visit will take 2 hours. The first study visit will take 3 hours. The second study visit will take 2 hours. The third study visit will take 9 hours. This study will include: a clinical interview, cognitive batteries, questionnaires and assessments related to your daily and psychiatric functioning, two 90 minute MRI scans of your brain, a fasting blood draw, and a urine drug screen and pregnancy test (for females). Compensation is up to $310. TO SEE IF YOU QUALIFY PLEASE CONTACT (205) 934-8203.
- Are you 18-60 years of age living with HIV, and want to be a part of a vaccine study?
- Is your viral load suppressed/undetectable?
- Are you able to receive a vaccine?
- Are you generally healthy?
- Are you willing to temporarily stop taking antiretrovirals?
You may qualify for a study looking at testing an experimental HIV vaccine with an experimental adjuvant to see how the immune responses change among participants who do an antiretroviral analytical treatment interruption (ATI) compared to those who do not. Compensation at each study visit will be provided for time and travel. Transportation services are also available upon request. If interested, please email sspaulding@uabmc.edu.
We're conducting clinical research in depression to learn how individuals’ brain biology impacts response to treatment, with the goal to help people find relief faster. You do not need to already have a diagnosis to participate.
If you’re currently taking medication, you are likely still eligible for our studies and don’t have to stop your existing treatment regimen.
For more information about this trial and to see if you qualify, please contact Kristine at kristinepike@uabmc.edu or 205-975-8542.
For more information about this trial and to see if you qualify, please contact Kristine at kristinepike@uabmc.edu or 205-975-8542.
• A woman on parole, probation, or recently released from prison or jail?
• A woman who has used drugs?
• Interested in learning about a way to protect yourself against HIV?
You may qualify for a paid research study at the University of Alabama at Birmingham, in partnership with Yale University.
• Participate in confidential study interviews at our research office.
• Earn $50 for each interview, up to $225 for participating in the study.
Fill out our contact survey at: https://yalesurvey.ca1.qualtrics.com/jfe/form/SV_d7sAjr6GDsjiJng?Q_CHL=qr
Or you may call: (205) 934-2851 or Email: AthenaStudy@uabmc.edu